PLATELET ALPHA(2)-ADRENERGIC RECEPTOR-BINDING AND THE EFFECTS OF D-AMPHETAMINE IN BOYS WITH ATTENTION-DEFICIT HYPERACTIVITY DISORDER

被引:6
|
作者
SHEKIM, WO
BYLUND, DB
HODGES, K
GLASER, R
RAYPRENGER, C
OETTING, G
机构
[1] UNIV NEBRASKA, MED CTR, DEPT PHARMACOL, LINCOLN, NE USA
[2] UNIV MISSOURI, DEPT PHARMACOL & PSYCHIAT, COLUMBIA, MO USA
关键词
ALPHA(2)-ADRENERGIC RECEPTOR; D-AMPHETAMINE; HYPERACTIVITY; NOREPINEPHRINE;
D O I
10.1159/000119074
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Presynaptic inhibitory alpha-adrenergic receptors are involved in regulating the release of norepinephrine (NE) through a negative feedback mechanism mediated by NE. Increased alpha(2)-adrenergic receptor activity suggests decrease NE release and activity, while decreased alpha(2)-adrenergic activity suggests increase NE release and activity. A large body of evidence suggests the involvement of a disturbance in NE activity in the pathophysiology of attention deficit hyperactivity disorder (ADHD) in childhood. Platelet alpha(2)-adrenergic receptor binding was compared in 23 boys aged 7-12 with the diagnosis of ADHD and 11 normal controls. The ADHD boys tended to have lower levels of alpha(2)-binding than controls. The administration of d-amphetamine in a double-blind placebo-controlled crossover design did not have any effect on alpha(2)-receptor binding in ADHD boys. Nonresponders to d-amphetamine had the lowest alpha(2)-receptor binding compared to responders and controls. These findings suggest a normal alpha(2)-adrenergic activity in ADHD boys responders to d-amphetamine and a possible increase in NE release in ADHD boys nonresponders to d-amphetamine due to decreased alpha(2)-adrenergic receptors.
引用
收藏
页码:120 / 124
页数:5
相关论文
共 50 条
  • [21] Electroencephalographic and Psychometric Differences Between Boys with and Without Attention-Deficit/Hyperactivity Disorder (ADHD): A Pilot Study
    Daniel J. Cox
    Boris P. Kovatchev
    James B. Morris
    Cheralee Phillips
    Rebecca J. Hill
    Larry Merkel
    Applied Psychophysiology and Biofeedback, 1998, 23 : 179 - 188
  • [22] Electroencephalographic and psychometric differences between boys with and without Attention-Deficit/Hyperactivity Disorder (ADHD): A pilot study
    Cox, DJ
    Kovatchev, BP
    Morris, JB
    Phillips, C
    Hill, RJ
    Merkel, L
    APPLIED PSYCHOPHYSIOLOGY AND BIOFEEDBACK, 1998, 23 (03) : 179 - 188
  • [23] What are the cognitive effects of stimulant medications? Emphasis on adults with attention-deficit/hyperactivity disorder (ADHD)
    Advokat, Claire
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2010, 34 (08) : 1256 - 1266
  • [24] An examination of the ocular effects of methylphenidate used in children and adolescents diagnosed with attention-deficit hyperactivity disorder
    Uzlu, Dilek
    Bilginer, Samiye cilem
    Yasar, Yasin
    Tasdemir, Cansu
    Erdol, Hidayet
    Gunay, Murat
    Kose, Busra
    INTERNATIONAL OPHTHALMOLOGY, 2025, 45 (01)
  • [25] Differential Treatment Effects of Methylphenidate and Atomoxetine on Executive Functions in Children with Attention-Deficit/Hyperactivity Disorder
    Wu, Chi-Shin
    Shang, Chi-Yung
    Lin, Hsiang-Yuan
    Gau, Susan Shur-Fen
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2021, 31 (03) : 187 - 196
  • [26] PLATELET ALPHA-2-ADRENERGIC RECEPTOR-BINDING TO H-3 YOHIMBINE AND PERSONALITY VARIATIONS IN NORMALS
    SHEKIM, WO
    BYLUND, DB
    FRANKEL, F
    ALEXSON, J
    CORCORAN, CM
    MCALLISTER, JM
    RAYPRENGER, C
    PSYCHIATRY RESEARCH, 1990, 32 (02) : 125 - 134
  • [27] Measurement of the subjective effects of methylphenidate in 11-to 15-Year-old children with attention-deficit/hyperactivity disorder
    Martin, Catherine A.
    Guenthner, Greg
    Bingcang, Christo Her
    Rayens, Mary Kay
    Kelly, Thomas H.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2007, 17 (01) : 63 - 73
  • [28] Behavioural effects of monoamine reuptake inhibitors on symptomatic domains in an animal model of attention-deficit/hyperactivity disorder
    Hiraide, Sachiko
    Ueno, Ken-ichi
    Yamaguchi, Taku
    Matsumoto, Machiko
    Yanagawa, Yoshiki
    Yoshioka, Mitsuhiro
    Togashi, Hiroko
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2013, 105 : 89 - 97
  • [29] Distinguishing the efficacy and sedative effects of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder
    Huss, Michael
    McBurnett, Keith
    Cutler, Andrew J.
    Hervas, Amaia
    Bliss, Caleb
    Gao, Joseph
    Dirks, Bryan
    Newcorn, Jeffrey H.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 (03) : 432 - 443
  • [30] Shared Genetic Factors Contributing to the Overlap between Attention-Deficit/Hyperactivity Disorder Symptoms and Overweight/Obesity in Swedish Adolescent Girls and Boys
    Javaras, Kristin N.
    Munn-Chernoff, Melissa A.
    Diemer, Elizabeth W.
    Thornton, Laura M.
    Bulik, Cynthia M.
    Yilmaz, Zeynap
    Lichtenstein, Paul
    Larsson, Henrik
    Baker, Jessica H.
    TWIN RESEARCH AND HUMAN GENETICS, 2022, 25 (06) : 226 - 233